Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Diabetes Metab J > Ahead-of print > Article
Review Metabolic Risk/Epidemiology Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Buorcid , Ziyan Sun, Yi Pan, Xia Dengorcid , Guoyue Yuanorcid

DOI: [Epub ahead of print]
Published online: April 1, 2024
  • 8 Download
  • 0 Crossref
  • 0 Scopus
Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
Corresponding author:  Xia Deng,
Guoyue Yuan,
Email: yuanguoyue@
Received: 14 August 2023   • Accepted: 1 January 2024

Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus. In recent years, basic and clinical studies have shown that GLP-1 is closely related to lipid metabolism, and it can participate in lipid metabolism by inhibiting fat synthesis, promoting fat differentiation, enhancing cholesterol metabolism, and promoting adipose browning. GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism. It is expected to become a new target for the treatment of metabolic disorders. The effects of GLP-1 and dual agonists on lipid metabolism also provide a more complete treatment plan for metabolic diseases. This article reviews the recent research progress of GLP-1 in lipid metabolism.

  • Cite
    export Copy
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    • Citation for the content below
    Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Related articles

Diabetes Metab J : Diabetes & Metabolism Journal